Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

This suggests that GLP-1 receptor agonists may offer a protective effect against the development of alcohol-related issues, particularly in the early months of treatment[5]. The mechanisms behind ...